drugset / Trial / NCT00537953

Short Course of Miltefosine and Antimony to Treat Cutaneous Leishmaniasis in Bolivia

NCT00537953

RandomizedParallel-groupOpen-labelTreatment

Summary

The combination of a half-course of miltefosine and a half-course of antimony will be evaluated for efficacy and tolerance. The combination of miltefosine and antimony is chosen because these are now the two standard agents in Bolivia, and in vitro the combination was additive to mildly synergistic against a standard leishmania strain.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Meglumine antimonate Other / unclassified
Subject Miltefosine Small molecule Oral